We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

137 hedge funds and large institutions have $1.37B invested in Sage Therapeutics in 2015 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 53 increasing their positions, 41 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 41

20% more funds holding in top 10

Funds holding in top 10: 5 → 6 (+1)

19% more capital invested

Capital invested by funds: $1.15B → $1.37B (+$217M)

17% more first-time investments, than exits

New positions opened: 27 | Existing positions closed: 23

2% more funds holding

Funds holding: 134 → 137 (+3)

25% less call options, than puts

Call options by funds: $5.22M | Put options by funds: $6.95M

Holders
137
Holders Change
+3
Holders Change %
+2.24%
% of All Funds
3.59%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.16%
New
27
Increased
53
Reduced
41
Closed
23
Calls
$5.22M
Puts
$6.95M
Net Calls
-$1.73M
Net Calls Change
-$7.77M

Top Buyers

Rank Fund Capital Flow
1
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$41.4M
2
BB
BB Biotech
Switzerland
+$35.1M
3
Millennium Management
Millennium Management
New York
+$25.7M
4
Jennison Associates
Jennison Associates
New York
+$12.6M
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$11.3M

Top Sellers

Rank Fund Capital Flow
1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$17.3M
2
GGHC
Gilder Gagnon Howe & Co
New York
-$15.1M
3
RG
Redmile Group
California
-$9.14M
4
HLA
Hamilton Lane Advisors
Pennsylvania
-$6.74M
5
O
OrbiMed
New York
-$6.35M
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
76
Harvey Capital Management
Florida
$1.03M -$91.6K -1,850 -9%
New York State Common Retirement Fund
77
New York State Common Retirement Fund
New York
$1.02M – – –
Swiss National Bank
78
Swiss National Bank
Switzerland
$1.02M – – –
ACP
79
Acuta Capital Partners
California
$984K +$836K +16,877 New
PWPCM
80
Perella Weinberg Partners Capital Management
New York
$888K +$2.08M +41,986 New
DekaBank Deutsche Girozentrale
81
DekaBank Deutsche Girozentrale
Germany
$858K +$17.3K +350 +2%
RhumbLine Advisers
82
RhumbLine Advisers
Massachusetts
$789K +$68.4K +1,380 +11%
SO
83
STRS Ohio
Ohio
$757K – – –
AQR Capital Management
84
AQR Capital Management
Connecticut
$688K -$266K -5,369 -31%
Ameriprise
85
Ameriprise
Minnesota
$646K -$1.25M -25,245 -70%
California Public Employees Retirement System
86
California Public Employees Retirement System
California
$583K – – –
MLICM
87
Metropolitan Life Insurance Company (MetLife)
New York
$568K – – –
Royal Bank of Canada
88
Royal Bank of Canada
Ontario, Canada
$536K +$416K +8,392 +1,025%
SM
89
Sabby Management
Florida
$474K -$1.58M -31,896 -80%
AIG
90
American International Group
New York
$471K -$694 -14 -0.2%
ACM
91
Atika Capital Management
New York
$467K +$396K +8,000 New
Citigroup
92
Citigroup
New York
$455K -$488K -9,845 -56%
SS
93
Simplicity Solutions
Minnesota
$455K +$387K +7,810 New
CIA
94
Capital Impact Advisors
Massachusetts
$453K – – –
PPA
95
Parametric Portfolio Associates
Washington
$451K +$383K +7,733 New
Morgan Stanley
96
Morgan Stanley
New York
$440K -$43.8K -884 -10%
DS
97
DRW Securities
Illinois
$408K +$347K +7,000 New
State Board of Administration of Florida Retirement System
98
State Board of Administration of Florida Retirement System
Florida
$390K +$18.3K +370 +6%
CS
99
Credit Suisse
Switzerland
$388K -$451K -9,097 -58%
BAMCO Inc
100
BAMCO Inc
New York
$373K -$352K -7,096 -53%
2 3
4
5 6

SAGE Hedge Fund Activity: Q4 2015 in Review

137 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q4 2015, worth a combined $1.37B — up 19% from $1.15B a quarter earlier.

Buyers outnumbered sellers: 27 funds opened new SAGE positions and 23 closed out — a net gain of 4 holders — while 53 added to existing stakes and 41 trimmed.

The largest buyer was Lord, Abbett & Co, adding an estimated $41.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $17.3M.

  • 137 institutional investors held Sage Therapeutics (SAGE) as of Q4 2015, up from 134 in Q3 2015.
  • Funds reported $1.37B of Sage Therapeutics stock for Q4 2015, up 19% quarter-over-quarter.
  • 27 funds opened new Sage Therapeutics positions in Q4 2015 and 23 closed out, a net change of +4 holders.
  • The largest Sage Therapeutics buyer in Q4 2015 was Lord, Abbett & Co, an estimated $41.4M added.
  • The largest Sage Therapeutics seller in Q4 2015 was T. Rowe Price Associates, an estimated $17.3M sold.

Based on aggregated 13F filings for Q4 2015.